Published in Diagn Interv Radiol on November 01, 2014
Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology (1990) 4.03
Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology (1999) 2.04
Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J (2007) 1.84
Missed breast cancers at US-guided core needle biopsy: how to reduce them. Radiographics (2007) 1.80
US-guided automated large-core breast biopsy. Radiology (1993) 1.75
Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer (1992) 1.51
Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.50
Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. Radiology (1999) 1.46
Percutaneous image-guided core breast biopsy. Radiol Clin North Am (2002) 1.41
Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am (2000) 1.25
Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer (2006) 1.22
Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol (2005) 1.11
Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy. Eur Radiol (2009) 1.06
Utility of 6-month follow-up imaging after a concordant benign breast biopsy result. Radiology (2010) 1.02
US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy. Breast Cancer Res Treat (2012) 0.92
Interventional breast imaging: current procedures and assessing for concordance with pathology. Radiol Clin North Am (2007) 0.92
MRI follow-up after concordant, histologically benign diagnosis of breast lesions sampled by MRI-guided biopsy. AJR Am J Roentgenol (2009) 0.92
Follow-up recommendations for benign breast biopsies. Breast J (2006) 0.87
Follow-up of breast lesions detected by MRI not biopsied due to absent enhancement of contrast medium. Eur Radiol (2002) 0.87
Use of breast core biopsy in the United States: results of a national survey. AJR Am J Roentgenol (1997) 0.83
Three- to six-year followup for 379 benign image-guided large-core needle biopsies of nonpalpable breast abnormalities. J Am Coll Surg (2002) 0.77
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol (2004) 1.63
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist (2011) 1.42
A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer (2003) 1.33
DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res (2006) 1.27
Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J (2004) 1.21
Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer (2010) 1.16
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer (2004) 1.12
Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw (2015) 1.12
A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. Mod Pathol (2011) 1.02
Gene expression profiling in breast cancer. Cancer Control (2010) 1.01
Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol (2007) 0.98
Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg (2004) 0.96
Impact of race on breast cancer in lower socioeconomic status women. Breast J (2006) 0.96
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care. J Oncol Pract (2011) 0.96
Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg (2007) 0.95
Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer (2011) 0.95
Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol (2010) 0.94
Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol (2009) 0.93
Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls. Cancer (2011) 0.93
Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma. Am J Surg Pathol (2010) 0.92
The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma. Am J Surg Pathol (2009) 0.91
Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol (2009) 0.91
The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma. Mod Pathol (2011) 0.90
Breast cancer risk reduction. J Natl Compr Canc Netw (2010) 0.88
Male breast cancer: management and follow-up recommendations. Breast J (2011) 0.88
Follow-up recommendations for benign breast biopsies. Breast J (2006) 0.87
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer (2012) 0.85
Phyllodes tumors: race-related differences. J Am Coll Surg (2011) 0.83
A unifying theory of carcinogenesis, and why targeted therapy doesn't work. Eur J Radiol (2012) 0.82
Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat (2009) 0.82
Effects of sentinel lymph node biopsy on surgical residency training. Am Surg (2006) 0.82
Evaluating patients with chronic pain after breast cancer surgery: the search for relief. JAMA (2009) 0.81
Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system. Cancer Control (2012) 0.80
Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer. J Surg Oncol (2014) 0.80
Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: an imaging classification system to guide management. Plast Reconstr Surg (2012) 0.79
Free nipple grafting: an alternative for patients ineligible for nipple-sparing mastectomy? Ann Plast Surg (2014) 0.79
Indications for axillary ultrasound use in breast cancer patients. Clin Breast Cancer (2012) 0.79
Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas. Mod Pathol (2013) 0.79
HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature. Ann Clin Lab Sci (2012) 0.79
Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy. Ann Surg Oncol (2015) 0.79
Challenges to developing proteomic-based breast cancer diagnostics. OMICS (2011) 0.79
The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol (2015) 0.78
Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography. Cancer Control (2012) 0.78
Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract (2011) 0.78
Breast cancer risk reduction. J Natl Compr Canc Netw (2007) 0.78
Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg (2004) 0.78
Multimodality imaging of hepato-biliary disorders in pregnancy: a pictorial essay. Emerg Radiol (2009) 0.76
Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma. Ann Surg Oncol (2011) 0.76
Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J (2009) 0.76
Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy. Ann Surg Oncol (2008) 0.76
Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. Am J Surg (2013) 0.76
Race of the clock: reducing delay to curative breast cancer surgery. J Natl Compr Canc Netw (2014) 0.76
Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis. Eplasty (2012) 0.75
Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol (2011) 0.75
Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging. Am Surg (2011) 0.75
Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy. Breast J (2012) 0.75
Shielding of the contralateral breast during tangential irradiation. Am J Clin Oncol (2004) 0.75
Ipsilateral nodal recurrence after axillary dissection for breast cancer. J Surg Res (2012) 0.75
Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer. Cancer Control (2017) 0.75
The "molecular" buzz in breast cancer. Cancer Control (2010) 0.75
Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS). J Surg Oncol (2015) 0.75
Prosthetic breast reconstruction after implant-sparing mastectomy in patients with submuscular implants. Ann Plast Surg (2011) 0.75
Going for the gold. Cancer Control (2012) 0.75
The pregnant breast cancer patient: are we failing our most vulnerable population? Ann Surg Oncol (2014) 0.75